The potential effects of ankaferd blood stopper and fibrin sealent on sleeve gastrectomy staple-line healing: An experimental study
Yükleniyor...
Dosyalar
Tarih
2019
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Spandidos Publ Ltd
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Staple-line bleeding and leakage is a life-threatening complication in obese patients following laparoscopic sleeve gastrectomy. The aim of this study was to examine the potential effects of Ankaferd blood stopper (ABS) and Fibrin Sealant (FS; Tisseel (R)) on sleeve gastrectomy staple-line healing in an experimental animal model. A total of 30 Wistar albino female rats were divided into three groups and were subjected to sleeve gastrectomy with linear stapling. Group A (control group) had nothing administered, Group B was administered FS on the staple-line, and Group C was administered ABS on the staple-line following sleeve gastrectomy. After sacrifice on postoperative day 5, anastomotic burst pressure, tissue hydroxyproline levels and histopathological parameters were measured. The results revealed that group C had the highest mean bursting pressure level. However, the values of this parameter were not found to differ significantly between the groups (P>0.05). Group B and C had a similar hydroxyproline levels but increased compared with group A (P<0.001). Histopathological parameters were similar between the groups, except macrophage scores in group C. In the present experimental study, ABS was demonstrated to improve gastric-sleeved staple-line healing compared with FS. ABS may be used as a novel reinforcement agent in bariatric surgery.
Açıklama
Anahtar Kelimeler
Obesity, Laparoscopic Sleeve Gastrectomy, Ankaferd Blood Stopper, Fibrin Sealent
Kaynak
Experimental and Therapeutic Medicine
WoS Q Değeri
Q4
Scopus Q Değeri
Cilt
18
Sayı
4
Künye
Sakar, A., Bilecik, T., Mayir, B., & Oruç, T. (2019). The potential effects of Ankaferd blood stopper and fibrin sealent on sleeve gastrectomy staple‑line healing: An experimental study. Experimental and therapeutic medicine, 18(4), 2519-2523.
